SA university reveals vaccine manufacturing plan
Australia could achieve vaccine self-reliance within half a year after the University of Adelaide (UA) revealed a plan to manufacture mRNA vaccines.
Stay updated with breaking news from Adelaide Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Australia could achieve vaccine self-reliance within half a year after the University of Adelaide (UA) revealed a plan to manufacture mRNA vaccines.
South Australian university reveals mRNA vaccine manufacturing plan South Australian university reveals mRNA vaccine manufacturing plan Last Updated: Wed, May 12th, 2021, 10:01:24hrs Canberra, May 12 (IANS) Australia could achieve vaccine self-reliance within half a year after the University of Adelaide (UA) revealed a plan to manufacture mRNA vaccines. The university on Wednesday announced a joint partnership with the South Australian Health and Medical Research Institute (SAHMRI) and international biotechnology company BioCina that could see it develop the capability to mass produce mRNA va...
2021-05-12 04:06:05 GMT2021-05-12 12:06:05(Beijing Time) Xinhua English CANBERRA, May 12 (Xinhua) -- Australia could achieve vaccine self-reliance within half a year after the University of Adelaide (UA) revealed a plan to manufacture mRNA vaccines. The university on Wednesday announced a joint partnership with the South Australian Health and Medical Research Institute (SAHMRI) and international biotechnology company BioCina that could see it develop the capability to mass produce mRNA vaccines within six months. Under the agreement, the Adelaide Pfizer plant purchased by BioCina in Au...
Australia Moots Plan to Manufacture mRNA Vaccines; Aims For Self Reliance in 6 Months By Vaccine for All Adult Americans by May 1 Australia could achieve vaccine self-reliance within half a year after the University of Adelaide (UA) revealed a plan to manufacture mRNA vaccines. The university on Wednesday announced a joint partnership with the South Australian Health and Medical Research Institute (SAHMRI) and international biotechnology company BioCina that could see it develop the capability to mass produce mRNA vaccines within six months. Under the agreement, the Adelaide Pfizer plant...